DaShenLin Pharmaceutical Group Co., Ltd.
603233
Rank in Stocks
#4768
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese... Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
Share Price
$2.76
Market Cap
$3.14B
Change (1 day)
2.36%
Change (1 year)
12.43%
Country
CN
Trade DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Category
Healthcare
EPS for DaShenLin Pharmaceutical Group Co., Ltd. (603233)
EPS as of June 2026 TTM: $0.18
According to DaShenLin Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is $0.18. At the end of 2023 the company had a EPS of $0.15 an increase over its 2022 EPS that were of $0.13.
EPS history for DaShenLin Pharmaceutical Group Co., Ltd. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.18 | 59.36% |
| 2024 | $0.11 | -23.71% |
| 2023 | $0.15 | 10.31% |
| 2022 | $0.13 | 19.80% |
| 2021 | $0.11 | -23.49% |
| 2020 | $0.14 | 59.01% |
| 2019 | $0.09 | 26.22% |
| 2018 | $0.07 | -0.69% |
| 2017 | $0.07 | 13.88% |
| 2016 | $0.06 | -10.45% |
| 2015 | $0.07 | 21.86% |
| 2014 | $0.06 | 30.56% |
| 2013 | $0.04 | -4.30% |
| 2012 | $0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | 9,780.21% |
US
|
|
| $-7.98 | -4,652.20% |
US
|
|
| $-5.29 | -3,117.68% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 15,724.30% |
NL
|
